Liposome-encapsulated EF24-HPβCD inclusion complex: A preformulation study and biodistribution in a rat model

Journal of Nanoparticle Research

Volumn 13, Issue 6, 2011, Pages 2609-2623

  Agashe, H ^a   Lagisetty, P ^a   Sahoo, K ^a   Bourne, D ^a   Grady, B ^b   Awasthi, V ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b University of Oklahoma   (United States)

Author keywords

Curcumin; EF24; Hydroxypropyl cyclodextrin; Inclusion complex; Liposomes; Nanomedicine

Indexed keywords

ANTI-PROLIFERATIVE; AQUEOUS SOLUBILITY; BIODISTRIBUTIONS; CO-ENCAPSULATION; CURCUMIN; DEHYDRATION-REHYDRATION; EF24; ENCAPSULATION EFFICIENCY; EXTRUSION TECHNIQUES; FREEZE-THAW CYCLES; GLUTATHIONES; IN-VITRO; INCLUSION COMPLEX; NANOMEDICINES; PHASE SOLUBILITY; POTENT ACTIVITY; PROSTATE CANCERS; RAT MODEL;

DISEASES; ENCAPSULATION; LIPOSOMES; MEDICAL NANOTECHNOLOGY; RATS; SOLUBILITY; TISSUE;

PHOSPHOLIPIDS;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 3,5 BIS(2 FLUOROBENZYLIDENE) 4 PIPERIDONE; ANTINEOPLASTIC AGENT; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; DISTEAROYLPHOSPHATIDYLCHOLINE; EF 24; GLUTATHIONE; LIPOSOME; PIPERIDONE DERIVATIVE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; DRUG UPTAKE; FREEZE THAWING; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER; MALE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PREFORMULATION; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SPLEEN; STOICHIOMETRY; TECHNIQUE; X RAY POWDER DIFFRACTION; ZETA POTENTIAL;

EID: 80052601569     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-010-0154-5     Document Type: Article

References (47)

1. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP, Shoji M (2005) EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 16:263-275 (Pubitemid 40283941)
2. Akerley W, Choy H (1999) Single-agent paclitaxel and radiation for non-small cell lung cancer. Semin Radiat Oncol 9:85-89 (Pubitemid 29190416)
3. American Cancer Society (2009) Cancer Statistics 2009 Presentation. American Cancer Society. http://www.cancer.org/docroot/PRO/content/PRO-1-1- Cancer-Statistics-2009-Presentation.asp
4. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807-818
5. Anderson M, Omri A (2004) The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Deliv 11:33-39 (Pubitemid 38292725)
6. Awasthi V, Goins B, Klipper R, Loredo R, Korvick D, Phillips WT (1998) Imaging experimental osteomyelitis using radiolabeled liposomes. J Nucl Med 39:1089-1094 (Pubitemid 28270133)
7. Awasthi VD, Garcia D, Goins BA, Phillips WT (2003) Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharm 253:121-132 (Pubitemid 36204032)
8. Awasthi VD, Garcia D, Klipper R, Goins BA, Phillips WT (2004a) Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly (ethylene glycol) - distearoylphosphatidylethanolamine on distribution and circulation kinetics. J Pharmacol Exp Ther 309:241-248 (Pubitemid 38393136)
9. Awasthi VD, Garcia D, Klipper R, Phillips WT, Goins BA (2004b) Kinetics of liposome-encapsulated hemoglobin after 25% hypovolemic exchange transfusion. Int J Pharm 283:53-62 (Pubitemid 39200926)
10. Awasthi V, Yee SH, Jerabek P, Goins B, Phillips WT (2007) Cerebral oxygen delivery by liposome-encapsulated hemoglobin: a positron-emission tomographic evaluation in a rat model of hemorrhagic shock. J Appl Physiol 103:28-38 (Pubitemid 47092274)
11. Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ (2002) Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother 46:828-833 (Pubitemid 34157670)
12. Bhardwaj U, Burgess DJ (2010) Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone. Int J Pharm 388:181-189
13. Brewster ME, Loftsson T (2007) Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59:645-666 (Pubitemid 47299263)
14. Challa R, Ahuja A, Ali J, Khar RK (2005) Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 6:E-E357
15. Fatouros DG, Hatzidimitriou K, Antimisiaris SG (2001) Liposomes encapsulating prednisolone and prednisolonecyclodextrin complexes: comparison of membrane integrity and drug release. Eur J Pharm Sci 13:287-296 (Pubitemid 32522581)
16. Frank DW (1976) Physiological data of laboratory animals. In: Melby ECJ (ed) Physiological data of laboratory animals. CRC Press, Boca Raton, FL, pp 23-64
17. Frijlink HW, Visser J, Hefting NR, Oosting R, Meijer DK, Lerk CF (1990) The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat. Pharm Res 7:1248-1252
18. Goins B, Klipper R, Rudolph AS, Cliff RO, Blumhardt R, Phillips WT (1993) Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J Nucl Med 34:2160-2168 (Pubitemid 24002960)
19. Gould S, Scott RC (2005) 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem Toxicol 43:1451-1459
20. Higuchi T, Connors K (1965) Phase solubility techniques. Adv Anal Chem Instrum 4:127-212
21. Ishida T, Kiwada H (2008) Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome. Yakugaku Zasshi 128:233-243 (Pubitemid 351237895)
22. Ishida T, Harashima H, Kiwada H (2002) Liposome clearance. Biosci Rep 22:197-224 (Pubitemid 35222732)
23. Ishida T, Wang X, Shimizu T, Nawata K, Kiwada H (2007) PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. J Control Release 122:349-355 (Pubitemid 47407760)
24. Kasinski AL, Du Y, Thomas SL, Zhao J, Sun SY, Khuri FR, Wang CY, Shoji M, Sun A, Snyder JP, Liotta D, Fu H (2008) Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcumin. Mol Pharmacol 74:654-661
25. Kirby C, Gregoriadis G (1984) Dehydration-rehydration vesicles (DRV): a new method for high yield drug entrapment in liposomes. Biotechnology 979-984 (Pubitemid 15090594)
26. Kume Y, Maeda F, Harashima H, Kiwada H (1991) Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system. J Pharm Pharmacol 43:162-166
27. Lagisetty P, Powell DR, Awasthi V (2009) Synthesis and structural determination of 3, 5-bis (2-fluorobenzylidene) - 4-piperidone analogs of curcumin. J Mol Str 936:23-28
28. Landegren U (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67:379-388 (Pubitemid 14163018)
29. Laverman P, Boerman OC, Oyen WJG, Corstens FHM, Storm G (2001) In vivo applications of PEG liposomes: unexpected observations. Critical reviews in therapeutic drug carrier systems 18:551-566 (Pubitemid 34024396)
30. Laverman P, Boerman OC, Storm G (2003) Radiolabeling of liposomes for scintigraphic imaging. Methods Enzymol 373:234-248 (Pubitemid 41103286)
31. Loftsson T, Hreinsdottir D, Masson M (2005a) Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 302:18-28 (Pubitemid 41244817)
32. Loftsson T, Jarho P, Masson M, Jarvinen T (2005b) Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2:335-351 (Pubitemid 41130887)
33. McCormack B, Gregoriadis G (1994) Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target 2:449-454
34. McCormack B, Gregoriadis G (1996) Comparative studies of the fate of free and liposome-entrapped hydroxypropylbeta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim Biophys Acta 1291:237-244 (Pubitemid 26403227)
35. McCormack B, Gregoriadis G (1998) Drugs-in-cyclodextrinsin-liposomes: an approach to controlling the fate of water insoluble drugs in vivo. Int J Pharm 162:59-69 (Pubitemid 28166091)
36. Petty C (1982) Research techniques in the rats. Charles C. Thomas, Springfield, IL (USA)
37. Phillips WT, Rudolph AS, Goins B, Timmons JH, Klipper R, Blumhardt R (1992) A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl Med Biol 19:539-547
38. Piel G, Piette M, Barillaro V, Castagne D, Evrard B, Delattre L (2007) Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. Int J Pharm 338:35-42 (Pubitemid 46777214)
39. Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, Kutala VK, Hideg K, Kuppusamy P (2007) EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem 282:28609-28618 (Pubitemid 47606012)
40. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP (2001) Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7:1894-1900 (Pubitemid 32994823)
41. Stewart JC (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10-14 (Pubitemid 10045896)
42. Subramaniam D, May R, Sureban SM, Lee KB, George R, Kuppusamy P, Ramanujam RP, Hideg K, Dieckgraefe BK, Houchen CW, Anant S (2008) Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res 68:1962-1969 (Pubitemid 351416583)
43. Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP (2006) Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. J Med Chem 49:3153-3158 (Pubitemid 43830514)
44. Szebeni J (1998) The interaction of liposomes with the complement system. Crit Rev Ther Drug Carrier Syst 15:57-88 (Pubitemid 28110564)
45. Szebeni J, Baranyi L, Savay S, Bodo M, Morse DS, Basta M, Stahl GL, Bunger R, Alving CR (2000) Liposomeinduced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am J Physiol 279:H-H1328
46. Walde P, Ichikawa S (2001) Enzymes inside lipid vesicles: preparation, reactivity and applications. Biomol Eng 18:143-177 (Pubitemid 32893963)
47. Woodle MC, Newman MS, Working PK (1995) Biological properties of sterically stabilized liposomes. In: Lasic DD, Martin F (eds) Stealth liposomes. CRC Press, Boca Raton, pp 103-117